{"d":{"__metadata":{"id":"https://ws.parlament.ch/OData.svc/Subject(ID=41828L,Language='FR')","uri":"https://ws.parlament.ch/OData.svc/Subject(ID=41828L,Language='FR')","type":"itsystems.Pd.DataServices.DataModel.Subject"},"Meetings":{"__metadata":{"id":"https://ws.parlament.ch/OData.svc/Meeting(ID=4012L,Language='FR')","uri":"https://ws.parlament.ch/OData.svc/Meeting(ID=4012L,Language='FR')","type":"itsystems.Pd.DataServices.DataModel.Meeting"},"Sessions":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Meeting(ID=4012L,Language='FR')/Sessions"}},"Subjects":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Meeting(ID=4012L,Language='FR')/Subjects"}},"ID":"4012","Language":"FR","MeetingNumber":9,"IdSession":5011,"SessionNumber":11,"SessionName":"Session d'hiver 2017","Council":1,"CouncilName":"Conseil national","CouncilAbbreviation":"CN","Date":"\/Date(1512950400000)\/","Begin":"1430","Modified":"\/Date(1516030926423)\/","LegislativePeriodNumber":50,"PublicationStatus":"final","MeetingOrderText":"Neuvi\u00e8me s\u00e9ance","SortOrder":9,"Location":"N"},"SubjectsBusiness":{"results":[{"__metadata":{"id":"https://ws.parlament.ch/OData.svc/SubjectBusiness(BusinessNumber=20175656,IdSubject=41828L,Language='FR')","uri":"https://ws.parlament.ch/OData.svc/SubjectBusiness(BusinessNumber=20175656,IdSubject=41828L,Language='FR')","type":"itsystems.Pd.DataServices.DataModel.SubjectBusiness"},"Subjects":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/SubjectBusiness(BusinessNumber=20175656,IdSubject=41828L,Language='FR')/Subjects"}},"Businesses":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/SubjectBusiness(BusinessNumber=20175656,IdSubject=41828L,Language='FR')/Businesses"}},"IdSubject":"41828","BusinessNumber":20175656,"Language":"FR","BusinessShortNumber":"17.5656","Title":"Polypharmacie dans les \u00e9tablissements m\u00e9dicosociaux. Risque de graves effets secondaires","SortOrder":1,"PublishedNotes":null,"Modified":"\/Date(1512981528726)\/","TitleDE":"Fragestunde.\nFrage Heim Bea.\nPolypharmazie in Pflegeheimen.\nRisiko von schweren Nebenwirkungen","TitleFR":"Heure des questions.\nQuestion Heim Bea.\nPolypharmacie\ndans les \u00e9tablissements m\u00e9dicosociaux.\nRisque de graves effets secondaires","TitleIT":null}]},"Transcripts":{"results":[{"__metadata":{"id":"https://ws.parlament.ch/OData.svc/Transcript(ID=223724L,Language='FR')","uri":"https://ws.parlament.ch/OData.svc/Transcript(ID=223724L,Language='FR')","type":"itsystems.Pd.DataServices.DataModel.Transcript"},"Subjects":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Transcript(ID=223724L,Language='FR')/Subjects"}},"MembersCouncil":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Transcript(ID=223724L,Language='FR')/MembersCouncil"}},"Businesses":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Transcript(ID=223724L,Language='FR')/Businesses"}},"ID":"223724","Language":"FR","IdSubject":"41828","VoteId":null,"PersonNumber":1161,"Type":1,"Text":"<pd_text><p>Ein Grossteil der Menschen, die in Pflegeheimen wohnen, hat dauerhafte Gesundheitsprobleme. Diese Multimorbidit\u00e4t f\u00fchrt dazu, dass diese Personen im Durchschnitt mehrere Medikamente gleichzeitig nehmen [PAGE 2016] m\u00fcssen. Aufgrund der Polymedikation m\u00fcssen die Nebenwirkungen und die m\u00f6glichen Interaktionen mit anderen Medikamenten gut abgestimmt werden. Unter Einhaltung der Sorgfaltspflichten sind Off-Label-Anwendungen zul\u00e4ssig und k\u00f6nnen medizinisch angezeigt sein. Die Verschreibung von Medikamenten inklusive deren Off-Label-Anwendungen liegt in der Verantwortung des behandelnden Arztes. Die \u00dcberwachung der \u00e4rztlichen T\u00e4tigkeiten liegt im Kompetenzbereich der Kantone. Ausserdem haben die Kantonsapotheker Empfehlungen zur Off-Label-Anwendung von Arzneimitteln f\u00fcr medizinische Fachpersonen publiziert.</p>\n</pd_text>","MeetingCouncilAbbreviation":"N","MeetingDate":"20171211","MeetingVerbalixOid":2955,"IdSession":"5011","SpeakerFirstName":"Alain","SpeakerLastName":"Berset","SpeakerFullName":"Berset Alain","SpeakerFunction":"VPBR-M","CouncilId":99,"CouncilName":"Conseil f\u00e9d\u00e9ral","CantonId":10,"CantonName":"Fribourg","CantonAbbreviation":"FR","ParlGroupName":null,"ParlGroupAbbreviation":null,"SortOrder":1,"Start":"\/Date(1513003866709)\/","End":"\/Date(1513003940555)\/","Function":"VPBR-M","DisplaySpeaker":true,"LanguageOfText":"DE","Modified":"\/Date(1774877286004)\/","StartTimeWithTimezone":"\/Date(1513003866710+0060)\/","EndTimeWithTimezone":"\/Date(1513003940557+0060)\/","VoteBusinessNumber":null,"VoteBusinessShortNumber":null,"VoteBusinessTitle":null}]},"ID":"41828","Language":"FR","IdMeeting":"4012","VerbalixOid":554806,"SortOrder":11,"Modified":"\/Date(1774877286000)\/"}}